Some of the most sought-after human experiences are health and happiness. Although pharmaceutical companies can’t determine personal happiness, they are having more to do with personal health outcomes that can tip the scale. The demand for personalized medicines, cell and gene therapies, hyperresponsive and patient-centric healthcare, and real-world data fueled by artificial intelligence (AI) platforms and stored in the cloud are just some examples of the personal touch that is driving the future of pharma.
"The FDA cannot ignore that the science and context in which previous regulatory decisions were made has changed, and we must be flexible to evolve with the data.”
FDA Commissioner Robert M. Califf
"Companies will need to operate with lower costs and shorter timelines while maintaining quality and encouraging innovation. That means reimagining work, tech enabling the organization, and advancing the portfolio to achieve multiple objectives simultaneously.”
PwC
Preparing for the future starts with knowing what’s coming. That’s why SeerPharma's business partner MasterControl* has prepared a report addressing the technology, regulatory, therapeutic and economic trends that will affect the pharmaceutical manufacturing industry this year:
*About MasterControl
With MasterControl quality management system (QMS) and manufacturing execution system (MES) software, you never have to sacrifice compliance to achieve efficiency. Our solutions are designed to ensure compliance with regulatory requirements while also increasing operational efficiency. By natively connecting quality and manufacturing data in one powerful digital tool, MasterControl enhances data connectivity and provides real-time visibility into processes across the entire life cycle of your regulated products.
Submit the form below to access the full MasterControl article 2024 Pharmaceutical Industry Trends.